Faculty of Pharmaceutical Sciences, Shonan University of Medical Sciences, 16-48 Kamishinano, Totsuka-ku, Yokohama, Kanagawa 244-0806, Japan
Koichi Kato
Faculty of Pharmaceutical Sciences, Shonan University of Medical Sciences, 16-48 Kamishinano, Totsuka-ku, Yokohama, Kanagawa 244-0806, Japan
Masaaki Kurihara
Faculty of Pharmaceutical Sciences, Shonan University of Medical Sciences, 16-48 Kamishinano, Totsuka-ku, Yokohama, Kanagawa 244-0806, Japan
Wanchun Jin
College of Pharmacy, Kinjo Gakuin University, 2-1723 Omori, Nagoya 463-8521, Japan
Tohru Koike
Department of Functional Molecular Science, Institute of Biochemical & Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan
Hiromasa Kurosaki
College of Pharmacy, Kinjo Gakuin University, 2-1723 Omori, Nagoya 463-8521, Japan
The two ZnII atoms in the crystal structure of the title complex, [Zn(NO3)2(C10H24N4)]·CH3OH, have a distorted octahedral coordination sphere, defined by 1,4,8,11-tetraazacyclotetradecane (cyclam) N atoms in the equatorial plane and nitrate O atoms in the axial sites. The conformation of the cyclam is trans-III (R, R, S, S), which is typical for metal–cyclam complexes. Nitrate anions are involved in intra- and intermolecular hydrogen bonding with the N–H groups of the ZnII–cyclam unit. Together with the methanol solvent molecule, the hydrogen-bonding network connects the ZnII–cyclam units into ribbons running parallel to the a axis.
